Related Articles
Sphingosine kinase 1: A novel independent prognosis biomarker in hepatocellular carcinoma
SPHK1 contributes to cisplatin resistance in bladder cancer cells via the NONO/STAT3 axis
SPHK1 promotes metastasis of thyroid carcinoma through activation of the S1P/S1PR3/Notch signaling pathway
Overexpression of sphingosine kinase 1 is predictive of poor prognosis in human breast cancer
Potential of a sphingosine 1‑phosphate receptor antagonist and sphingosine kinase inhibitors as targets for multiple myeloma treatment